Accretive Wealth Partners, LLC has made headlines with its recent 13F-HR filing, which was submitted on November 6, 2026. This report details the firm's investment holdings as of September 30, 2026, and provides insight into its financial strategies and portfolio adjustments. The filing is significant as it highlights the firm's position in the market and may influence trends within the financial services sector.

Background

Accretive Wealth Partners, LLC is based in Parsippany, New Jersey. The firm operates within the financial services industry and focuses on investment management. Its recent filings include various 13F-HR reports, with the latest one dated November 6, 2026, and previous filings dating back to August 5, 2026, and July 29, 2026. The firm is registered under the Central Index Key (CIK) number 0001844444.

What the Filing Says

The latest 13F-HR filing indicates that Accretive Wealth Partners holds significant investments across various sectors. The report details a total value of $469,521,343 across 172 different positions. Notable holdings include major companies such as Abbott Laboratories, AbbVie Inc, and Alphabet Inc. The firm has also invested in a variety of exchange-traded funds (ETFs) and other financial instruments.

Impact

This filing may affect various stakeholders, including investors, analysts, and competitors within the financial services industry. By revealing its investment strategies, Accretive Wealth Partners provides valuable insights that could influence market trends and competitive strategies. Other firms in the sector may analyze this filing to adjust their own investment approaches in response to Accretive's moves.

What's Next

The filing does not specify what happens next for Accretive Wealth Partners. However, stakeholders will likely be monitoring the firm's future filings and market moves closely.

Source: Accession number 0001765380-26-000441